Molecular Oncology
Volume 4, Issue 2 , Pages 150-160 , April 2010

Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab

  • Gerald W. Prager

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • Both the authors contributed equally to this work.
    • ,
  • Eva-Maria Lackner

      Affiliations

    • Department of Ophthalmology, Medical University Graz, A-8020 Vienna, Austria
    • Both the authors contributed equally to this work.
    • ,
  • Maria-Theresa Krauth

      Affiliations

    • Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria
    • ,
  • Matthias Unseld

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Marina Poettler

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Sylvia Laffer

      Affiliations

    • Ludwig Boltzmann, Cluster Oncology, A-1090 Vienna, Austria
    • ,
  • Sabine Cerny-Reiterer

      Affiliations

    • Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria
    • ,
  • Wolfgang Lamm

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Gabriela V. Kornek

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Bernd R. Binder

      Affiliations

    • Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Christoph C. Zielinski

      Affiliations

    • Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, A-1090 Vienna, Austria
    • Ludwig Boltzmann, Cluster Oncology, A-1090 Vienna, Austria
    • ,
  • Peter Valent

      Affiliations

    • Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria
    • Ludwig Boltzmann, Cluster Oncology, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University Vienna, A-1090 Vienna, Austria. Tel.: +43 1 40400 6085; fax: +43 1 40400 4030.

Received 28 August 2009 ,Revised 29 December 2009 ,Accepted 4 January 2010.

References 

  1. Al-Hajj M, Wicha MS, ito-Hernandez A, Morrison SJ, Clarke MF. Proc. Natl. Acad. Sci. U.S. A. 2003;100:3983–3988
  2. Bergers G, Benjamin LE. Nat. Rev. Cancer. 2003;3:401–410
  3. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, et al. J. Natl. Cancer Inst. 1995;87:506–516
  4. Cailleau R, Olive M, Cruciger QV. In Vitro. 1978;14:911–915
  5. Carmeliet P, Jain RK. Nature. 2000;407:249–257
  6. Carmeliet P. Nat. Med. 2000;6:389–395
  7. Cho D, Signoretti S, Regan M, Mier JW, Atkins MB. Clin. Cancer Res. 2007;13:758s–763s
  8. Cresanta JL. Prim. Care. 1992;19:419–441
  9. Daub H, Specht K, Ullrich A. Nat. Rev. Drug Discov. 2004;3:1001–1010
  10. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Am. J. Pathol. 1995;146:1029–1039
  11. Dvorak HF. J. Clin. Oncol. 2002;20:4368–4380
  12. Ferrara N. Endocr. Rev. 2004;25:581–611
  13. Ferrara N. Oncology. 2005;69(Suppl. 3):11–16
  14. Gasparini G, Longo R, Toi M, Ferrara N. Nat. Clin. Pract. Oncol. 2005;2:562–577
  15. Gerber HP, Ferrara N. Cancer Res. 2005;65:671–680
  16. Giatromanolaki A, Koukourakis MI, Turley H, Sivridis E, Harris AL, Gatter KC. Mod. Pathol. 2006;19:701–707
  17. Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, et al. J. Clin. Oncol. 2008;26:313–325
  18. Guba M, von BP, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Nat. Med. 2002;8:128–135
  19. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Nature. 1999;400:464–468
  20. Hamed EA, El-Noweihi AM, Mohamed AZ, Mahmoud A. Respirology. 2004;9:81–86
  21. Herbst RS. Expert. Opin. Emerg. Drugs. 2006;11:635–650
  22. Hunter T. Cell. 1997;88:333–346
  23. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. N. Engl. J. Med. 2004;350:2335–2342
  24. Jimeno A, Rudek MA, Kulesza P, Ma WW, Wheelhouse J, Howard A, et al. J. Clin. Oncol. 2008;26:4172–4179
  25. Jones PA, Baylin SB. Nat. Rev. Genet. 2002;3:415–428
  26. Jovov B, Wills NK, Lewis SA. Am. J. Physiol. 1991;261:C1196–C1203
  27. Kerr DJ. Nat. Clin. Pract. Oncol. 2004;1:39–43
  28. Kirsch M, Schackert G, Black PM. J. Neurooncol. 2000;50:173–180
  29. Mayerhofer M, Valent P, Sperr WR, Griffin JD, Sillaber C. Blood. 2002;100:3767–3775
  30. Mayerhofer M, Aichberger KJ, Florian S, Krauth MT, Hauswirth AW, Derdak S, et al. FASEB J. 2005;19:960–962
  31. Mellado B, Gascon P. Clin. Transl. Oncol. 2006;8:706–710
  32. Mercurio AM, Bachelder RE, Bates RC, Chung J. Semin. Cancer Biol. 2004;14:115–122
  33. Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, et al. N. Engl. J. Med. 2007;357:2666–2676
  34. Morin MJ. Oncogene. 2000;19:6574–6583
  35. Numnum TM, Rocconi RP, Whitworth J, Barnes MN. Gynecol. Oncol. 2006;102:425–428
  36. Ochiumi T, Kitadai Y, Tanaka S, Akagi M, Yoshihara M, Chayama K. Int. J. Oncol. 2006;29:105–116
  37. Parkin DM. Lancet Oncol. 2001;2:533–543
  38. Pfaffl MW. Nucleic Acids Res. 2001;29:e45
  39. Pichelmayer O, Gruenberger B, Zielinski C, Raderer M. Ann. Oncol. 2006;17:1853
  40. Prager GW, Breuss JM, Steurer S, Olcaydu D, Mihaly J, Brunner PM, et al. Circ. Res. 2004;
  41. Prager GW, Breuss JM, Steurer S, Mihaly J, Binder BR. Blood. 2004;103:955–962
  42. Prager GW, Mihaly J, Brunner PM, Koshelnick Y, Hoyer-Hansen G, Binder BR. Blood. 2009;113:1383–1390
  43. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, et al. N. Engl. J. Med. 2006;355:2542–2550
  44. Schwartz GK, Shah MA. J. Clin. Oncol. 2005;23:9408–9421
  45. Shawver LK, Slamon D, Ullrich A. Cancer Cell. 2002;1:117–123
  46. Timoshenko AV, Rastogi S, Lala PK. Br. J. Cancer. 2007;97:1090–1098
  47. Tonra JR, Hicklin DJ. Immunol. Invest. 2007;36:3–23
  48. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L. J. Cell Biol. 2001;152:1247–1254
  49. Vales A, Kondo R, Aichberger KJ, Mayerhofer M, Kainz B, Sperr WR, et al. Leuk. Lymphoma. 2007;48:1997–2007
  50. Van CS, Van Den BW. Anat. Histol. Embryol. 2002;31:214–223
  51. Weigand M, Hantel P, Kreienberg R, Waltenberger J. Angiogenesis. 2005;8:197–204
  52. Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, et al. N. Engl. J. Med. 2003;349:427–434
  53. Yano S, Nokihara H, Hanibuchi M, Parajuli P, Shinohara T, Kawano T, et al. Oncol. Res. 1997;9:573–579
  54. Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, Ellis LM, et al. Am. J. Pathol. 2000;157:1893–1903

PII: S1574-7891(10)00003-7

doi: 10.1016/j.molonc.2010.01.002

Molecular Oncology
Volume 4, Issue 2 , Pages 150-160 , April 2010

Article Tools

* Image Usage & Resolution